MannKind Corporation (MNKD)
NASDAQ: MNKD · Real-Time Price · USD
4.570
-0.150 (-3.18%)
At close: May 14, 2025, 4:00 PM
4.718
+0.148 (3.24%)
After-hours: May 14, 2025, 7:10 PM EDT
MannKind Employees
As of December 31, 2024, MannKind had 407 total employees, including 403 full-time and 4 part-time employees. The number of employees decreased by 7 or -1.69% compared to the previous year.
Employees
407
Change (1Y)
-7
Growth (1Y)
-1.69%
Revenue / Employee
$731,192
Profits / Employee
$73,995
Market Cap
1.39B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
MNKD News
- 1 day ago - MannKind to Present at Upcoming Investor Conferences - GlobeNewsWire
- 6 days ago - MannKind Corporation (MNKD) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 6 days ago - MannKind Corporation Reports First Quarter 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 13 days ago - MannKind Corporation to Hold 2025 First Quarter Financial Results Conference Call on May 8, 2025 - GlobeNewsWire
- 5 weeks ago - MannKind Teams Up with Juncos Hollinger Racing (JHR) Driver Conor Daly to Drive Awareness of Diabetes and Innovative Treatment Options - GlobeNewsWire
- 2 months ago - MannKind Showcases Efficacy, Safety, and Mealtime Control Data from Recent Pediatric and Adult Studies of Afrezza® at the ATTD Conference, March 19-22 - GlobeNewsWire
- 2 months ago - MannKind Q4 Review: Solid Financials, But Tyvaso DPI's Market Share In Question - Seeking Alpha
- 2 months ago - MannKind Corporation (MNKD) Q4 2024 Earnings Call Transcript - Seeking Alpha